Research Publications

Review Papers
  • Mehra S, Fritzler MJ.The spectrum of anti-chromatin / nucleosome autoantibodies: independent and interdependent biomarkers of disease. J Immunol Res. 2014;2014:368274. Epub 2014 Apr 3.
  • Mehra S, Walker J, Patterson K, Fritzler MJ. Autoantibodies in systemic sclerosis.Autoimmun Rev. 2013 Jan;12(3):340-54
  • Rajadhyaksha AG, Mehra S, Nadkar MY. Biologics in SLE: The current status. J Assoc Physicians India. 2013 Apr;61(4):262-7.
Research Paper
  • Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ. Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.
    . J Rheumatol. 2017 Jun;44(6):799-805.
  • Negi VS1, Muralidharan N, Mehra S, Devaraju P, Mariaselvam CM, Gulati R, Salah S, Fortier C, Charron D, Krishnamoorthy R, Tamouza R. IRF5rs2004640 single nucleotide polymorphism is associated with susceptibility to rheumatoid arthritis in South Indian Tamils.
    Tissue Antigens. 2014 Oct 6. doi: 10.1111/tan.12441. [Epub ahead of print]
  • Devaraju P, Reni BN, Gulati R, Mehra S, Negi VS. Complement C1q and C2 polymorphisms are not risk factors for SLE in Indian Tamils.Immunobiology.
    Immunobiology. 2014 Jun;219(6):465-8. Epub 2014 Feb 25.
  • Mehra S, Hudson M, Mahler M. Canadian Scleroderma Research Group, Baron M, Fritzler M; Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?
    Rheumatol Int. 2013 Mar 31.
  • Hudson M, Satoh M, Chan JY, Tatibouet S, Mehra S, Baron M, Fritzler MJ, And The Canadian Scleroderma Research Group A. Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects.
    ClinExpRheumatol. 2013 Oct 21. [Epub ahead of print]
Oral Presentations
  • IRACON 2016M. Comparing the efficacy of Low Dose versus High Dose Cyclophosphamide Regimen as Induction Therapy in the Treatment of Proliferative Lupus Nephritis
  • IRACON 2013 IRF5rs2004640 single nucleotide polymorphism is associated with susceptibility to rheumatoid arthritis in South Indian Tamils
Poster Presentations
  • APLAR 2015 HLA-DRB1*03 Is A Genetic Risk Factor For Juvenile Systemic Lupus Erythematosus In South Indian Tamils
  • IRACON 2014 Lupus nephritis in South Indian tamilmonocentric cohort: Association between clinical and autoantibody expression
  • IRACON 2013 Is there an association between Ro52/TRIM21 antibodies and rheumatoid factor in systemic sclerosis?
Case Reports
  • Rajadhakshya A, Mehra S.Dengue fever evolving into systemic lupus erythematosus and lupus nephritis: a case report.
    Lupus. 2012 Aug;21(9):999-1002. PMID 22354536
  • Rajadhyaksha A, Baheti TG, Mehra S, Sonawale AS, Jain N. Dermatomyositis: a rare presentation of HIV seroconversion illness.
    J ClinRheumatol. 2012 Sep;18(6):298-300.
  • Rajadhyaksha A, Mehra S, Kawale J. Disseminated Strongyloides in systemic lupus erythematosus and antiphospholipid antibody syndrome: a case report.
    Int J Rheum Dis. 2012 Dec;15(6):e159-61
  • Rajadhyaksha A, Mehra S. Pharyngeal-cervical-brachial variant of Guillain-Barre syndrome with predominant bulbar palsy as the initial presentation of systemic lupus erythematosus and lupus nephritis
    a case report Int J Rheum Dis. 2012 Dec;15(6):e162-4. Epub 2012 Jul 9.
Abstracts
  • Influence Of HLA-DRB1 & DQB1 Alleles On Susceptibility, Clinical Manifestations And Autoantibody Repertoire Of Systemic Lupus Erythematosus In South Indian Tamils S. Mehra1, C.M. Mariaselvam1, C. Fortier2, R. Krishnamoorthy2, R. Tamouza2, V.S. Negi Ann Rheum Dis 2015;74:898 annrheumdis-2015-eular.4903
  • Heterogeneity Of Autoantibodies In Systemic Sclerosis: Reconsidering Current Paradigms. Mehra1, Sonal, Baron2, Murray, Stephenson1, Mat, Hudson3, Marie, Pope4, Janet E., Canadian Scleroderma Research Group, , Fritzler1, Marvin J. Arthritis & Rheumatism, Volume 64, November 2012 Abstract Supplement
  • V.K. Jain, P.T. Antony, C.B. Mithun, B.K. Singh, S. Mehra, J. Usdadiya, V.S. Negi. AB0559 “Hypokalemic paralysis in primary Sjogren syndrome: is it a distinct clinical subset which requires lifelong potassium supplementation rather than immunosuppressants ? ” Annals of Rheumatic diseases .10.1136/annrheumdis-2014-eular.1739
Book Chapter
  • Psychiatric manifestations in Rheumatoid Arthritis: Manual of rheumatology 2017 (in print)
Under Review
  • The IRF5 rs200460 (G/T) polymorphism is not a genetic risk factor for SLE in Indian Tamils
  • Comparing the efficacy of Low Dose versus High Dose Cyclophosphamide Regimen as Induction Therapy in the Treatment of Proliferative Lupus Nephritis